Back to Chevy Chase Trust Holdings, LLC

REGN
Showing 8 of 30 quarters

Position history for Chevy Chase Trust Holdings, LLC's holdings in REGENERON PHARMACEUTICALS

Chevy Chase Trust Holdings, LLC holds 205,833 shares of REGN (REGENERON PHARMACEUTICALS), worth $159M as of 2026-Q1. The position was increased (+2.5% shares). REGN represents 0.5% of Chevy Chase Trust Holdings, LLC's portfolio.

Current Value

$159M

Current Shares

205,833

Total Value Change

-$95.1M

Total Shares Change

-35,921

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
205,833
+2.5%
$159M0.5%$766.66
37
2025-Q4
Decreased
200,747
-1.2%
$155M0.4%$773.94
0
2025-Q3
Decreased
203,152
-1.7%
$114.2M0.3%$560.05
0
2025-Q2
Decreased
206,728
-6.5%
$108.5M0.3%$519.56
0
2025-Q1
Decreased
221,210
-3.7%
$140.3M0.4%$634.66
0
2024-Q4
Decreased
229,767
-3.6%
$163.7M0.5%$698.71
0
2024-Q3
Decreased
238,379
-1.4%
$250.6M0.8%$1,036.94
0
2024-Q2
Decreased
241,754
-0.3%
$254.1M0.8%$1,045.23
0

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used